Background ABO blood groups have been suggested to contribute to the development of certain tumors; however, the associations between ABO blood groups and the incidence and metastases of cutaneous malignant melanomas have not been fully evaluated in Chinese populations. Thus, we investigated these associations with a case-controlled study in northeast of China. Methods A total of 482 patients with cutaneous malignant melanoma and 3,068 healthy- controls were enrolled for the study between 2001 and 2012 at The Tumor Hospital of Harbin Medical University. A multivariate logistic model was used to evaluate adjusted odds ratios (ORs) and 95% confidence intervals (CI) for the incidence and metastases of cutaneous malignant melanoma. Results Blood type A individuals had higher tumor incidence and metastasis compared to those with blood type O (OR = 1.575; 95% CI = 1.208–2.053, p = 0.001; OR = 2.004; 95% CI = 1.032–3.889, p = 0.040), after adjusting for age, gender, smoking status and alcohol consumption. Conclusions Blood type A was associated with higher incidence and metastasis of cutaneous malignant melanoma but future studies are needed to examine the mechanisms linking cutaneous malignant melanoma to ABO blood types.
References
[1]
Lee C, Collichio F, Ollila D, Moschos S (2013) Historical review of melanoma treatment and outcomes. Clin Dermatol 31: 141–147. doi: 10.1016/j.clindermatol.2012.08.015
[2]
Moan J, Baturaite Z, Porojnicu AC, Dahlback A, Juzeniene A (2012) UVA, UVB and incidence of cutaneous malignant melanoma in Norway and Sweden. Photochem Photobiol Sci 11: 191–198. doi: 10.1039/c1pp05215b
[3]
Naldi L, Altieri A, Imberti GL, Gallus S, Bosetti C, et al. (2005) Sun Exposure, Phenotypic Characteristics, and Cutaneous Malignant Melanoma. An Analysis According to Different Clinico-Pathological Variants and Anatomic Locations (Italian). Cancer Causes and Control 16: 893–899. doi: 10.1007/s10552-005-2300-4
[4]
Han J, Colditz GA, Hunter DJ (2006) Risk factors for skin cancers: a nested case-control study within the Nurses’ Health Study. Int J Epidemiol 35: 1514–1521. doi: 10.1093/ije/dyl197
[5]
Li Q, Yu CH, Yu JH, Liu L, Xie SS, et al. (2012) ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLOS ONE. 7: e29928. doi: 10.1371/journal.pone.0029928
[6]
Song HR, Shin MH, Kim HN, Piao JM, Choi JS, et al. (2013) Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population. Gastric Cancer 16: 254–260. doi: 10.1007/s10120-012-0176-z
[7]
Rizzato C, Campa D, Pezzilli R, Soucek P, Greenhalf W, et al. (2013) ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 29: 1637–1644. doi: 10.3892/or.2013.2285
[8]
Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, et al. (2012) ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control 23: 1805–1810. doi: 10.1007/s10552-012-0059-y
[9]
Wang Z, Liu L, Ji J, Zhang J, Yan M, et al. (2012) ABO Blood Group System and Gastric Cancer: A Case-Control Study and Meta-Analysis. Int J Mol Sci 13: 13308–13321. doi: 10.3390/ijms131013308
[10]
Nakao M, Matsuo K, Ito H, Shitara K, Hosono S, et al. (2011) ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev 20: 1665–1672. doi: 10.1158/1055-9965.epi-11-0213
[11]
Ben Q, Wang K, Yuan Y, Li Z (2011) Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer 128: 1179–1186. doi: 10.1002/ijc.25426
[12]
Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24: 4340–4346. doi: 10.1200/jco.2006.06.2984
[13]
Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353: 2135–2147. doi: 10.1056/nejmoa050092
[14]
Whiteman DC, Pavan WJ, Bastian BC (2011) The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res 24: 879–897. doi: 10.1111/j.1755-148x.2011.00880.x
[15]
Aird I, Bentall HH, Roberts JA (1953) A relationship between cancer of stomach and the ABO blood groups. Br Med J 1: 799–801. doi: 10.1136/bmj.1.4814.799
[16]
Greer JB, Yazer MH, Raval JS, Barmada MM, Brand RE, et al. (2010) Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol 16: 5588–5591. doi: 10.3748/wjg.v16.i44.5588
[17]
Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS (2011) ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 128: 482–486. doi: 10.1002/ijc.25339
[18]
Xie J, Qureshi AA, Li Y, Han J (2010) ABO blood group and incidence of skin cancer. PLOS ONE 5: e11972. doi: 10.1371/journal.pone.0011972
[19]
de Giorgi V, Grazzini M, Gori A, Alfaioli B, Rossari S, et al. (2011) ABO blood group and risk of cutaneous malignant melanoma. Eur J Cancer Prev 20: 121–122. doi: 10.1097/cej.0b013e3283429e1d
[20]
Pare G, Chasman DI, Kellogg M, Zee RY, Rifai N, et al. (2008) Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome - wide association study of 6,578 women. PLoS Genet 4: e1000118. doi: 10.1371/journal.pgen.1000118
[21]
Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, et al. (2008) A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet 4: e1000072. doi: 10.1371/journal.pgen.1000072
[22]
Yamada M, Yanaba K, Takehara K, Sato S (2005) Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma. Arch Dermatol Res 297: 256–260. doi: 10.1007/s00403-005-0605-5
[23]
de Lima VC, de Carvalho AF, Morato-Marques M, Hashimoto VL, Spilborghs GM, et al. (2013) TNF-alpha and melphalan modulate a specific group of early expressed genes in a murine melanoma model. Cytokine 62: 217–225. doi: 10.1016/j.cyto.2013.02.022
[24]
Sheng L, Sun X, Zhang L, Su D (2013) ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer 133: 893–897. doi: 10.1002/ijc.28087
[25]
Beckman L, Angqvist KA (1987) On the mechanism behind the association between ABO blood groups and gastric carcinoma. Hum Hered 37: 140–143. doi: 10.1159/000153691
[26]
Jaff MS (2010) Higher frequency of secretor phenotype in O blood group - its benefits in prevention and/or treatment of some diseases. Int J Nanomedicine 5: 901–905. doi: 10.2147/ijn.s13980
